Company Overview of The GI Company, Inc.
The GI Company, Inc., a clinical-stage biotechnology company, develops drugs to treat gastrointestinal and related diseases. It offers intestinal trefoil factor for the treatment of oral mucositis. The company also has projects in enteritis/proctitis, inflammatory bowel disease, erosive gastroesophageal reflux disease, peptic ulcer disease, and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis, ulcerative colitis, and corneal wound healing. The GI Company, Inc. was incorporated in 1998 and is based in Framingham, Massachusetts.
1661 Worcester Road
Framingham, MA 01701
Founded in 1998
Key Executives for The GI Company, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact The GI Company, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.